Sanofi-Aventis s.r.o. is a Czech Republic-based subsidiary of the multinational pharmaceutical company Sanofi S.A. The Czech Company is the owner of Zentiva, the Prague-based branded generics producer, which was bought by Sanofi in 2008 for EUR 1.8 bil. Sanofi S.A. is the world's fifth-largest pharmaceutical company by prescription sales. The Company was formed as Sanofi-Aventis in 2004 by the merger of Aventis and Sanofi-Synthélabo, which were each the product of several previous mergers. It changed its name to Sanofi in May 2011. Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical drugs principally in the prescription market, but the firm also develops over-the-counter medication. The company covers 7 major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines..
This report offers a summary of the Company's performance in 2001-2013. You will find here all the key numbers from the Company's balance sheet, income statement and cash flow and main ratios related to the Company's business